Journal of Current Ophthalmology

CASE REPORT
Year
: 2022  |  Volume : 34  |  Issue : 1  |  Page : 115--117

Intracameral injection of methotrexate for treatment of epithelial ingrowth


Farhad Salari, Ghasem Fakhraie, Fahimeh Asadi Amoli, Mehran Zarei-Ghanavati 
 Department of Cornea, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran

Correspondence Address:
Mehran Zarei-Ghanavati
Farabi Eye Hospital, Qazvin Square, Tehran
Iran

Purpose: To report a case of intracameral injection of methotrexate (MTX) to treat the epithelial ingrowth that occurred following glaucoma surgery. Methods: A case report of a 40-year-old male with epithelial ingrowth after implantation of Ahmed glaucoma valve. Results: The patient was treated with 11 doses of weekly intracameral MTX (400 mg/0.1 ml). Clinical evidence of recurrence was not observed after 11 months of follow-up. Discussion: Intracameral MTX can be used as an alternative for the treatment of epithelial ingrowth.


How to cite this article:
Salari F, Fakhraie G, Amoli FA, Zarei-Ghanavati M. Intracameral injection of methotrexate for treatment of epithelial ingrowth.J Curr Ophthalmol 2022;34:115-117


How to cite this URL:
Salari F, Fakhraie G, Amoli FA, Zarei-Ghanavati M. Intracameral injection of methotrexate for treatment of epithelial ingrowth. J Curr Ophthalmol [serial online] 2022 [cited 2022 Jun 24 ];34:115-117
Available from: http://www.jcurrophthalmol.org/article.asp?issn=2452-2325;year=2022;volume=34;issue=1;spage=115;epage=117;aulast=Salari;type=0